Efficacy and Safety of BGG492 as Adjunctive Treatment in Patients With Partial Onset Seizures

Clinical trial NCT01147003 · COMPLETED

Trial details

NCT number: NCT01147003
Sponsor: Novartis
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Partial Onset Seizures

Start date: 2010-06-01
Primary completion: 2011-09-01
Enrollment: 93

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.